← Back
$ORMP All transactions

ORAMED PHARMACEUTICALS INC.

A

$ Value

$0

Shares

109,000

Price

$0

Filed

Jan 5

Insider

Name

KIDRON NADAV

Title

President and CEO

CIK

0001351779

Roles

Director Officer

Transaction Details

Transaction Date

2025-12-31

Code

A

Table

Derivative

Ownership

Direct

Equity Swap

No

Shares After

109,000

Footnotes

Represents Restricted Stock Units ("RSUs") that vested in full on January 1, 2026. Each RSU represents the right to receive one share of common stock, par value $0.012 per share ("Common Stock"), of the Issuer. | Represents RSUs that will vest in quarterly installments over a three-year period starting January 1, 2026. Each RSU represents the right to receive one share of Common Stock of the Issuer. | Each performance stock unit ("PSU") represents a contingent right to receive one share of the Issuer's Common Stock. The PSUs vest upon the achievement of either (i) the Issuer's Common Stock achieving a specified price per share, or (ii) the achievement of the applicable performance criteria.

Filing Info

Accession No.

0001213900-26-001280

Form Type

4

Issuer CIK

0001176309

KIDRON NADAV's History

Date Ticker Type Value
2026-03-30 ORMP F $148K
2026-03-25 LFWD A $0
2026-03-17 ORMP A $0
2026-03-12 ORMP G $0
2026-01-22 ORMP M $0
2026-01-22 ORMP M $0
2025-12-31 ORMP A $0
2025-12-31 ORMP A $0
2025-12-31 ORMP A $0

Other Insiders at ORMP (90d)

Insider Bought Sold Last
KIDRON NADAV
President and CEO
2026-03-30
Kidron Miriam
Chief Scientific Officer
2026-03-30
Hexter Joshua
COO & CBO
2026-03-17
Gabay Avraham
Chief Financial Officer
2026-03-17